You are on the new improved site. You can view the old site in view-only mode here until June 27, 2026

Filter Results

Search all journals

Enter search terms…

Advanced search

/

About

About Sage
About Sage Journals
Privacy Policy
Terms of Use
Contact Us
Help

Information for

Authors
Editors
Librarians
Researchers
Reviewers
Frequently asked questions

Copyright © 2026 by Sage Publications.京ICP备09090397号-11

Search results

Search results page

Articles (7)

Journals (0)

1-7 of 7 results for Lenvatinib (36)

Sort by:

Relevance

Select all

Select all

Sort by:

Relevance

Select article: Increased Progression-Free Survival with Cabozantinib Versus Placebo in Patients with Radioiodine-Refractory Differentiated Thyroid Cancer Irrespective of Prior Vascular Endothelial Growth Factor Receptor-Targeted Therapy and Tumor Histology: A Subgroup Analysis of the COSMIC-311 Study

Retricted access

Research article

First published 2024-03

Increased Progression-Free Survival with Cabozantinib Versus Placebo in Patients with Radioiodine-Refractory Differentiated Thyroid Cancer Irrespective of Prior Vascular Endothelial Growth Factor Receptor-Targeted Therapy and Tumor Histology: A Subgroup Analysis of the COSMIC-311 Study

Jaume Capdevila, Jolanta Krajewska, Jorge Hernando [...]

Thyroid®

Select article: Real-World Experience with Lenvatinib plus Pembrolizumab in Metastatic BRAF Wild-Type Anaplastic Thyroid Carcinoma

Retricted access

Research article

First published 2026-2

Real-World Experience with Lenvatinib plus Pembrolizumab in Metastatic BRAF Wild-Type Anaplastic Thyroid Carcinoma

Sarah Hamidi, Danica M. Vodopivec, Naifa L. Busaidy [...]

Thyroid®

Select article: TACE Combined with Lenvatinib and Camrelizumab for Unresectable Multiple Nodular and Large Hepatocellular Carcinoma (>5 cm)

Open access

Research article

First published 2023

TACE Combined with Lenvatinib and Camrelizumab for Unresectable Multiple Nodular and Large Hepatocellular Carcinoma (>5 cm)

Zhanwang Xiang, Guohong Li, Luwen Mu [...]

Technology in Cancer Research & Treatment

Select article: Durable responses to immune checkpoint inhibitor-based regimens for metastatic clear cell renal cell carcinoma stratified by IMDC risk groups: A pooled analysis of four randomized phase 3 trials

Open access

Research article

First published 2025

Durable responses to immune checkpoint inhibitor-based regimens for metastatic clear cell renal cell carcinoma stratified by IMDC risk groups: A pooled analysis of four randomized phase 3 trials

Albert Jang, Jeffrey Y. Zhong, Hamsa L.S. Kumar [...]

Kidney Cancer

Select article: Multikinase Inhibitors for the Treatment of Asymptomatic Radioactive Iodine-Refractory Differentiated Thyroid Cancer: Global Noninterventional Study (RIFTOS MKI)

Retricted access

Research article

First published 2022-09

Multikinase Inhibitors for the Treatment of Asymptomatic Radioactive Iodine-Refractory Differentiated Thyroid Cancer: Global Noninterventional Study (RIFTOS MKI)

Marcia S. Brose, Johannes W.A. Smit, Chia-Chi Lin [...]

Thyroid®

Select article: Reporting on Adverse Clinical Events

Retricted access

Research article

First published 2026-2

Reporting on Adverse Clinical Events

Clin-Alert

Select article: Reporting on Adverse Clinical Events

Retricted access

Research article

First published 2025-2

Reporting on Adverse Clinical Events

Clin-Alert

1
10 / page

Article type

Publication date

Subjects

Access